(Q24299743)

GOA release 2020-03-11

1 reference

5

0 references

Daniel Kirchhofer

6

object named as

Daniel Kirchhofer

0 references

author name string

Paul Moran

1

0 references

Wei Li

2

0 references

Bin Fan

3

0 references

Rajesh Vij

Journal of Biological Chemistry

4

0 references

language of work or name

English

0 references

publication date

13 October 2006

0 references

published in

0 references

volume

281

0 references

issue

41

0 references

page(s)

30439-46

0 references

describes a project that uses

LNCaP-17

0 references

LNCaP-34

0 references

cites work

The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepsin promotes prostate cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Development and Characterization of Murine Monoclonal Antibodies to the Latency-Associated Peptide of Transforming Growth Factor β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Characterization of placental bikunin, a novel human serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Prostate cancer and the met hepatocyte growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

The urokinase-type plasminogen activator system in prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Possible role of matriptase in the diagnosis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Structure of human urokinase plasminogen activator in complex with its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

inferred from DOI database lookup

7 January 2021

based on heuristic

Urokinase-type plasminogen activator expression in human prostate carcinomas

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200

inferred from DOI database lookup

7 January 2021

based on heuristic

Plasminogen activation and cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605440200